177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma

Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT

(2020) Yaping Luo et al.   CLINICAL NUCLEAR MEDICINE

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

(2020) Liang Zhao et al.   CLINICAL NUCLEAR MEDICINE

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

(2020) Haojun Chen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Fibroblast activation protein targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET/CT

(2020) Yaping Luo et al.   JOURNAL OF NUCLEAR MEDICINE

A new method for tumor imaging by targeting cancer associated fibroblasts

(2018) Anastasia Loktev et al.   JOURNAL OF NUCLEAR MEDICINE

FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers

(2018) Frederik Giesel et al.   JOURNAL OF NUCLEAR MEDICINE

Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment

(2018) Jens T. Siveke   JOURNAL OF NUCLEAR MEDICINE

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

(2014) Elizabeth J. Hamson et al.   Proteomics Clinical Applications

Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma

(2009) Steven J. Cohen et al.   PANCREAS